Coloplast stock holds steady as investors weigh recent guidance and valuation
Published on 09/18/2026 at 11:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Coloplast stock (ISIN DK0060448595) last closed at around 417.90 Danish kroner on Nasdaq Copenhagen on September 17, 2026, leaving the medical device group valued in the mid-cap range and trading notably below the average analyst target price as of mid-September 2026.
Analysts reassess Coloplast valuation
According to MarketScreener on September 17, 2026, Coloplast stock closed at 419.40 Danish kroner in the prior session, while the average analyst target price stood at 468.29 Danish kroner, implying an upside of 11.66 percent based on that close.
The same overview from MarketScreener reported a mean consensus rating of Hold from 21 analysts, showing that the market remains divided between Coloplast’s premium valuation and its defensive growth profile.
Price performance and trading range
Per data summarized by MarketScreener on September 17, 2026, Coloplast shares traded at 417.90 Danish kroner with a daily change of minus 0.36 percent and a volume of 78,450 shares on that day.
In the same source, the five-day price history showed the stock moving between 416.10 Danish kroner and 419.70 Danish kroner in the week to September 17, 2026, underlining a relatively tight trading range despite broader market volatility.
Stock valuation versus history
On a euro-adjusted Frankfurt listing, Coloplast’s German-traded shares under the ticker CBHD.F closed at 55.90 in local currency on September 17, 2026, down 0.75 percent on the day, with a 52-week range between 49.72 and 82.96 according to Yahoo Finance.
This Frankfurt quote suggests that, relative to its 52-week high of 82.96 in that market, Coloplast’s German listing is trading significantly below its peak, while still holding above the 52-week low of 49.72 as of the same September 17, 2026 snapshot.
Closing price and investor perspective
On Nasdaq Copenhagen, Coloplast stock was last quoted around 417.90 Danish kroner as of September 17, 2026, with investors monitoring how upcoming updates to guidance and margins might influence the gap between the current price and the average analyst target.
Coloplast stock key data
- Company: Coloplast A/S
- ISIN: DK0060448595
- Ticker: COLO B
- Trading venue: Nasdaq Copenhagen
- Price (as of September 17, 2026): 417.90 DKK
- Sector / Industry: Health Care / Medical Devices
- Index membership: OMX Copenhagen 20
